ARDX
HealthcareArdelyx, Inc.
$5.80+0.14 (+2.47%)
Prev Close
$5.66
Open
$5.70
High
$5.89
Low
$5.65
Volume
2.03M
Market Cap
$1.51B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Ardelyx, Inc. (ARDX) has been mixed between buying and selling, with 6 insider purchases totaling $7.30M and 40 insider sales totaling $4.13M. The most recent insider transaction was by RAAB MICHAEL (director, officer: President & CEO), who sold $260.6K worth of shares on Feb 25, 2026. Ardelyx, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.51B.
Buys (12M)
6
$7.30M
Sells (12M)
40
$4.13M
Net Activity
Net Buyer
$3.16M
Active Insiders
11
last 12 mo
ARDX Price Chart
ARDX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026↗ | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $6.26 | $260.6K | 1,836,150 |
| Feb 23, 2026↗ | Bishop John E | officer: See Remarks | Sell | 3,179 | $5.85 | $18.6K | 339,538 |
| Feb 23, 2026↗ | Brady James Parker | officer: Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 263,221 |
| Feb 23, 2026↗ | Foster Eric Duane | officer: Chief Commercial Officer | Sell | 10,438 | $5.85 | $61.0K | 427,233 |
| Feb 23, 2026↗ | Hohenleitner Susan | officer: Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 230,780 |
| Feb 23, 2026↗ | Kelliher Mike | officer: See Remarks | Sell | 9,595 | $5.85 | $56.1K | 365,827 |
| Feb 23, 2026↗ | MOTT DAVID M | director | Buy | 333,333 | $5.84 | $1.95M | 3,302,920 |
| Feb 23, 2026↗ | RAAB MICHAEL | director, officer: President & CEO | Sell | 45,980 | $5.85 | $268.8K | 1,862,570 |
| Feb 23, 2026↗ | Reilly Joseph James | officer: See Remarks | Sell | 4,991 | $5.85 | $29.2K | 152,394 |
| Feb 23, 2026↗ | Williams Laura A | officer: See Remarks | Sell | 8,176 | $5.85 | $47.8K | 437,066 |
| Feb 20, 2026↗ | Bishop John E | See Remarks | Sell | 3,179 | $5.85 | $18.6K | 0 |
| Feb 20, 2026↗ | Brady James Parker | Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 0 |
| Feb 20, 2026↗ | Foster Eric Duane | Chief Commercial Officer | Sell | 10,439 | $5.85 | $61.0K | 0 |
| Feb 20, 2026↗ | Hohenleitner Susan | Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 0 |
| Feb 20, 2026↗ | Kelliher Mike | See Remarks | Sell | 9,595 | $5.85 | $56.1K | 0 |
| Feb 20, 2026↗ | MOTT DAVID M | Director | Buy | 333,333 | $5.84 | $1.95M | 0 |
| Feb 20, 2026↗ | RAAB MICHAEL | President & CEO | Sell | 45,982 | $5.85 | $268.8K | 0 |
| Feb 20, 2026↗ | Reilly Joseph James | See Remarks | Sell | 4,991 | $5.85 | $29.2K | 0 |
| Feb 20, 2026↗ | Williams Laura A | See Remarks | Sell | 8,176 | $5.85 | $47.8K | 0 |
| Jan 9, 2026↗ | Williams Laura A | officer: Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 361,563 |
| Jan 8, 2026↗ | Williams Laura A | Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 0 |
| Nov 21, 2025↗ | Foster Eric Duane | Chief Commercial Officer | Sell | 5,814 | $5.54 | $32.2K | 0 |
| Nov 21, 2025↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 5,995 | $5.54 | $33.2K | 0 |
| Nov 21, 2025↗ | Kelliher Mike | See Remarks | Sell | 5,560 | $5.54 | $30.8K | 0 |
| Nov 21, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 46,887 | $5.54 | $259.6K | 0 |
| Nov 21, 2025↗ | Reilly Joseph James | See Remarks | Sell | 11,086 | $5.54 | $61.4K | 0 |
| Nov 21, 2025↗ | Williams Laura A | Chief Patient Officer | Sell | 6,426 | $5.54 | $35.6K | 0 |
| Aug 26, 2025↗ | Williams Laura A | Chief Patient Officer | Sell | 80,000 | $6.12 | $489.7K | 0 |
| Aug 21, 2025↗ | Foster Eric Duane | Chief Commercial Officer | Sell | 15,308 | $5.93 | $90.8K | 0 |
| Aug 21, 2025↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 5,841 | $5.93 | $34.6K | 0 |
| Aug 21, 2025↗ | Kelliher Mike | Chief Business Officer | Sell | 5,417 | $5.93 | $32.1K | 0 |
| Aug 21, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 45,687 | $5.93 | $271.0K | 0 |
| Aug 21, 2025↗ | Renz Justin A | Chief Financial Officer | Sell | 7,037 | $5.93 | $41.7K | 0 |
| Aug 21, 2025↗ | Williams Laura A | Chief Patient Officer | Sell | 6,261 | $5.93 | $37.1K | 0 |
| Jun 16, 2025↗ | MOTT DAVID M | Director | Buy | 200,000 | $3.63 | $725.9K | 0 |
| Jun 9, 2025↗ | MOTT DAVID M | Director | Buy | 200,000 | $3.69 | $737.3K | 0 |
| May 20, 2025↗ | Foster Eric Duane | Chief Commercial Officer | Sell | 2,507 | $4.08 | $10.2K | 0 |
| May 20, 2025↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 5,992 | $4.08 | $24.5K | 0 |
| May 20, 2025↗ | Kelliher Mike | See Remarks | Sell | 14,522 | $4.08 | $59.3K | 0 |
| May 20, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 46,817 | $4.08 | $191.1K | 0 |
| May 20, 2025↗ | Renz Justin A | Chief Financial Officer | Sell | 7,218 | $4.08 | $29.5K | 0 |
| May 20, 2025↗ | Williams Laura A | Chief Medical Officer | Sell | 6,421 | $4.08 | $26.2K | 0 |
| May 15, 2025↗ | MOTT DAVID M | Director | Buy | 100,000 | $3.29 | $329.1K | 0 |
| May 2, 2025↗ | MOTT DAVID M | Director | Buy | 381,377 | $4.22 | $1.61M | 0 |
| May 2, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 41,666 | $4.25 | $177.2K | 0 |
| Apr 4, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 41,666 | $4.59 | $191.2K | 0 |
| Mar 7, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 41,668 | $5.36 | $223.2K | 0 |
| Feb 24, 2025↗ | MOTT DAVID M | Director | Buy | 77,729 | $5.00 | $388.7K | 0 |
| Feb 20, 2025↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 4,291 | $5.62 | $24.1K | 0 |
| Feb 20, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 22,964 | $5.62 | $129.1K | 0 |
| Feb 20, 2025↗ | Renz Justin A | Chief Financial Officer | Sell | 5,171 | $5.62 | $29.1K | 0 |
| Feb 20, 2025↗ | Williams Laura A | Chief Medical Officer | Sell | 4,941 | $5.62 | $27.8K | 0 |
| Jan 31, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 41,666 | $5.36 | $223.4K | 0 |
| Jan 21, 2025↗ | MOTT DAVID M | Director | Buy | 199,000 | $4.99 | $992.7K | 0 |
| Jan 7, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 41,666 | $5.31 | $221.3K | 0 |
| Dec 19, 2024↗ | MOTT DAVID M | Director | Buy | 213,300 | $4.67 | $996.6K | 0 |
| Dec 10, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 25,000 | $5.26 | $131.6K | 0 |
| Nov 25, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 25,000 | $5.38 | $134.5K | 0 |
| Nov 20, 2024↗ | Blanks Robert | See Remarks | Sell | 4,941 | $4.79 | $23.7K | 0 |
| Nov 20, 2024↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 7,046 | $4.79 | $33.8K | 0 |
| Nov 20, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 31,980 | $4.79 | $153.3K | 0 |
| Nov 20, 2024↗ | Renz Justin A | Chief Financial Officer | Sell | 5,260 | $4.79 | $25.2K | 0 |
| Nov 20, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 7,184 | $4.79 | $34.4K | 0 |
| Nov 20, 2024↗ | Williams Laura A | Chief Medical Officer | Sell | 7,366 | $4.79 | $35.3K | 0 |
| Nov 13, 2024↗ | MOTT DAVID M | Director | Buy | 215,868 | $4.62 | $996.6K | 0 |
| Nov 11, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 2,743 | $4.90 | $13.4K | 0 |
| Nov 6, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 27,171 | $6.10 | $165.7K | 0 |
| Nov 4, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 27,172 | $5.95 | $161.7K | 0 |
| Oct 28, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 25,000 | $5.91 | $147.7K | 0 |
| Oct 11, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 7,500 | $6.01 | $45.1K | 0 |
| Sep 27, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 49,564 | $6.92 | $343.0K | 0 |
| Sep 26, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 3,000 | $6.07 | $18.2K | 0 |
| Sep 13, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 5,312 | $6.26 | $33.3K | 0 |
| Sep 11, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 35,000 | $5.61 | $196.4K | 0 |
| Aug 27, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 7,500 | $6.22 | $46.6K | 0 |
| Aug 20, 2024↗ | Blanks Robert | See Remarks | Sell | 4,969 | $5.86 | $29.1K | 0 |
| Aug 20, 2024↗ | Felsch Robert Ora | See Remarks | Sell | 3,567 | $5.86 | $20.9K | 0 |
| Aug 20, 2024↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 7,089 | $5.86 | $41.5K | 0 |
| Aug 20, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 32,225 | $5.86 | $188.8K | 0 |
| Aug 20, 2024↗ | Renz Justin A | Chief Financial Officer | Sell | 5,289 | $5.86 | $31.0K | 0 |
| Aug 20, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 7,219 | $5.86 | $42.3K | 0 |
| Aug 20, 2024↗ | Williams Laura A | Chief Medical Officer | Sell | 7,412 | $5.86 | $43.4K | 0 |
| Aug 16, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 40,507 | $5.97 | $241.8K | 0 |
| Aug 12, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 1,229 | $5.71 | $7.0K | 0 |
| Jul 29, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 30,000 | $5.64 | $169.3K | 0 |
| Jul 15, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 7,500 | $5.97 | $44.8K | 0 |
| Jun 28, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 2,310 | $6.59 | $15.2K | 0 |
| Jun 21, 2024↗ | Blanks Robert | See Remarks | Sell | 38,000 | $5.96 | $226.3K | 0 |
| Jun 13, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 35,000 | $6.65 | $232.7K | 0 |
| Jun 5, 2024↗ | Williams Laura A | Chief Medical Officer | Sell | 145,000 | $7.12 | $1.03M | 0 |
| Jun 3, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 17,872 | $7.00 | $125.1K | 0 |
| May 29, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 7,500 | $6.72 | $50.4K | 0 |
| May 21, 2024↗ | Blanks Robert | See Remarks | Sell | 4,855 | $7.81 | $37.9K | 0 |
| May 21, 2024↗ | Felsch Robert Ora | See Remarks | Sell | 3,485 | $7.81 | $27.2K | 0 |
| May 21, 2024↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 6,927 | $7.81 | $54.1K | 0 |
| May 21, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 31,484 | $7.81 | $245.9K | 0 |
| May 21, 2024↗ | Renz Justin A | Chief Financial Officer | Sell | 5,167 | $7.81 | $40.4K | 0 |
| May 21, 2024↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 6,703 | $7.81 | $52.4K | 0 |
| May 21, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 7,053 | $7.81 | $55.1K | 0 |
| May 21, 2024↗ | Williams Laura A | Chief Medical Officer | Sell | 4,794 | $7.81 | $37.4K | 0 |
| May 14, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 3,000 | $7.99 | $24.0K | 0 |
| May 6, 2024↗ | Felsch Robert Ora | See Remarks | Sell | 207,988 | $8.81 | $1.83M | 0 |
| May 6, 2024↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 284,170 | $8.88 | $2.52M | 0 |
| May 3, 2024↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 45,000 | $9.00 | $405.0K | 0 |
| May 3, 2024↗ | Williams Laura A | Chief Medical Officer | Sell | 39,949 | $8.35 | $333.6K | 0 |
| Apr 29, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 30,000 | $6.40 | $192.1K | 0 |
| Apr 15, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 7,500 | $7.06 | $52.9K | 0 |
| Apr 1, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 1,518 | $7.31 | $11.1K | 0 |
| Mar 20, 2024↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 86,000 | $7.73 | $665.0K | 0 |
| Feb 26, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 5,183 | $9.20 | $47.7K | 0 |
| Feb 20, 2024↗ | Blanks Robert | See Remarks | Sell | 5,017 | $8.75 | $43.9K | 0 |
| Feb 20, 2024↗ | Felsch Robert Ora | See Remarks | Sell | 2,352 | $8.75 | $20.6K | 0 |
| Feb 20, 2024↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 4,432 | $8.75 | $38.8K | 0 |
| Feb 20, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 22,917 | $8.75 | $200.4K | 0 |
| Feb 20, 2024↗ | Renz Justin A | Chief Financial Officer | Sell | 5,341 | $8.75 | $46.7K | 0 |
| Feb 20, 2024↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 6,928 | $8.75 | $60.6K | 0 |
| Feb 20, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 7,311 | $8.75 | $63.9K | 0 |
| Feb 20, 2024↗ | Williams Laura A | Chief Medical Officer | Sell | 4,803 | $8.75 | $42.0K | 0 |
| Feb 8, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 15,344 | $9.18 | $140.8K | 0 |
| Jan 8, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 30,000 | $6.64 | $199.2K | 0 |
| Dec 26, 2023↗ | Renz Justin A | Chief Financial Officer | Sell | 225,000 | $6.36 | $1.43M | 0 |
| Dec 18, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 5,675 | $6.07 | $34.4K | 0 |
| Dec 14, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 7,000 | $5.55 | $38.9K | 0 |
| Dec 11, 2023↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 50,000 | $5.08 | $253.9K | 0 |
| Dec 8, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 20,000 | $5.27 | $105.5K | 0 |
| Dec 5, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 10,272 | $5.00 | $51.4K | 0 |
| Nov 30, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 3,000 | $4.50 | $13.5K | 0 |
| Nov 20, 2023↗ | Blanks Robert | See Remarks | Sell | 2,835 | $4.36 | $12.4K | 0 |
| Nov 20, 2023↗ | Felsch Robert Ora | See Remarks | Sell | 1,044 | $4.36 | $4.6K | 0 |
| Nov 20, 2023↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 2,384 | $4.36 | $10.4K | 0 |
| Nov 20, 2023↗ | RAAB MICHAEL | President & CEO | Sell | 11,368 | $4.36 | $49.6K | 0 |
| Nov 20, 2023↗ | Renz Justin A | Chief Financial Officer | Sell | 2,873 | $4.36 | $12.5K | 0 |
| Nov 20, 2023↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 4,714 | $4.36 | $20.6K | 0 |
| Nov 20, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 3,767 | $4.36 | $16.4K | 0 |
| Nov 20, 2023↗ | Williams Laura A | Chief Medical Officer | Sell | 2,581 | $4.36 | $11.3K | 0 |
| Nov 15, 2023↗ | Williams Laura A | Chief Medical Officer | Sell | 25,000 | $4.00 | $100.0K | 0 |
| Oct 10, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 1,644 | $4.00 | $6.6K | 0 |
| Sep 8, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 2,897 | $4.55 | $13.2K | 0 |
| Aug 21, 2023↗ | Blanks Robert | See Remarks | Sell | 2,846 | $3.55 | $10.1K | 0 |
| Aug 21, 2023↗ | Felsch Robert Ora | See Remarks | Sell | 1,048 | $3.55 | $3.7K | 0 |
| Aug 21, 2023↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 2,392 | $3.55 | $8.5K | 0 |
| Aug 21, 2023↗ | RAAB MICHAEL | President & CEO | Sell | 11,419 | $3.55 | $40.6K | 0 |
| Aug 21, 2023↗ | Renz Justin A | Chief Financial Officer | Sell | 2,884 | $3.55 | $10.2K | 0 |
| Aug 21, 2023↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 4,733 | $3.55 | $16.8K | 0 |
| Aug 21, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 3,783 | $3.55 | $13.4K | 0 |
| Aug 21, 2023↗ | Williams Laura A | Chief Medical Officer | Sell | 2,591 | $3.55 | $9.2K | 0 |
| Jun 27, 2023↗ | Williams Laura A | Chief Medical Officer | Sell | 25,000 | $3.35 | $83.6K | 0 |
| Jun 23, 2023↗ | Blanks Robert | See Remarks | Sell | 33,333 | $3.63 | $121.0K | 0 |
| May 23, 2023↗ | Blanks Robert | See Remarks | Sell | 2,835 | $3.65 | $10.4K | 0 |
| May 23, 2023↗ | Felsch Robert Ora | See Remarks | Sell | 1,046 | $3.65 | $3.8K | 0 |
| May 23, 2023↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 2,384 | $3.65 | $8.7K | 0 |
| May 23, 2023↗ | RAAB MICHAEL | President & CEO | Sell | 11,357 | $3.65 | $41.5K | 0 |
| May 23, 2023↗ | Renz Justin A | Chief Financial Officer | Sell | 2,873 | $3.65 | $10.5K | 0 |
| May 23, 2023↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 4,711 | $3.65 | $17.2K | 0 |
| May 23, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 3,769 | $3.65 | $13.8K | 0 |
| May 23, 2023↗ | Williams Laura A | Chief Medical Officer | Sell | 2,583 | $3.65 | $9.4K | 0 |
| Mar 29, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 3,000 | $4.63 | $13.9K | 0 |
| Feb 21, 2023↗ | Blanks Robert | See Remarks | Sell | 3,394 | $3.00 | $10.2K | 0 |
| Feb 21, 2023↗ | Felsch Robert Ora | See Remarks | Sell | 3,214 | $3.00 | $9.6K | 0 |
| Feb 21, 2023↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 2,914 | $3.00 | $8.7K | 0 |
| Feb 21, 2023↗ | RAAB MICHAEL | President & CEO | Sell | 13,449 | $3.00 | $40.4K | 0 |
| Feb 21, 2023↗ | Renz Justin A | Chief Financial Officer | Sell | 3,439 | $3.00 | $10.3K | 0 |
| Feb 21, 2023↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 5,586 | $3.00 | $16.8K | 0 |
| Feb 21, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 4,508 | $3.00 | $13.5K | 0 |
| Feb 21, 2023↗ | Williams Laura A | Chief Medical Officer | Sell | 3,187 | $3.00 | $9.6K | 0 |
| Nov 22, 2022↗ | Blanks Robert | See Remarks | Sell | 1,464 | $1.95 | $2.9K | 0 |
| Nov 22, 2022↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 1,242 | $1.95 | $2.4K | 0 |
| Nov 22, 2022↗ | RAAB MICHAEL | President & CEO | Sell | 6,219 | $1.95 | $12.1K | 0 |
| Nov 22, 2022↗ | Renz Justin A | Chief Financial Officer | Sell | 1,504 | $1.95 | $2.9K | 0 |
| Nov 22, 2022↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 3,456 | $1.95 | $6.7K | 0 |
| Nov 22, 2022↗ | Rosenbaum David P. | Chief Development Officer | Sell | 1,948 | $1.95 | $3.8K | 0 |
| Nov 22, 2022↗ | Williams Laura A | Chief Medical Officer | Sell | 1,241 | $1.95 | $2.4K | 0 |
| Nov 17, 2022↗ | MOTT DAVID M | Director | Buy | 567,000 | $1.76 | $1.00M | 0 |
| Oct 5, 2022↗ | Blanks Robert | See Remarks | Sell | 100,000 | $1.50 | $150.0K | 0 |
| Aug 31, 2022↗ | Felsch Robert Ora | See Remarks | Buy | 3,000 | $0.62 | $1.9K | 0 |
| Aug 31, 2022↗ | GRAMMER ELIZABETH A | See Remarks | Buy | 3,000 | $0.62 | $1.9K | 0 |
| Aug 31, 2022↗ | RAAB MICHAEL | President & CEO | Buy | 3,000 | $0.62 | $1.9K | 0 |
| Aug 31, 2022↗ | Renz Justin A | Chief Financial Officer | Buy | 3,000 | $0.62 | $1.9K | 0 |
| Aug 31, 2022↗ | Rosenbaum David P. | Chief Development Officer | Buy | 3,000 | $0.62 | $1.9K | 0 |
| Aug 31, 2022↗ | Rosenbaum David P. | Chief Development Officer | Sell | 3,000 | $0.92 | $2.8K | 0 |
| Aug 31, 2022↗ | Williams Laura A | Chief Medical Officer | Buy | 3,000 | $0.62 | $1.9K | 0 |
| Aug 26, 2022↗ | Blanks Robert | See Remarks | Sell | 21,842 | $1.04 | $22.7K | 0 |
| Aug 22, 2022↗ | Blanks Robert | See Remarks | Sell | 1,458 | $0.98 | $1.4K | 0 |
| Aug 22, 2022↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 1,236 | $0.98 | $1.2K | 0 |
| Aug 22, 2022↗ | RAAB MICHAEL | President & CEO | Sell | 6,146 | $0.98 | $6.0K | 0 |
| Aug 22, 2022↗ | Renz Justin A | Chief Financial Officer | Sell | 1,498 | $0.98 | $1.5K | 0 |
| Aug 22, 2022↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 3,420 | $0.98 | $3.4K | 0 |
| Aug 22, 2022↗ | Rosenbaum David P. | Chief Development Officer | Sell | 1,955 | $0.98 | $1.9K | 0 |
| Aug 22, 2022↗ | Williams Laura A | Chief Medical Officer | Sell | 1,276 | $0.98 | $1.3K | 0 |
| Jul 26, 2022↗ | Blanks Robert | See Remarks | Sell | 5,188 | $0.67 | $3.5K | 0 |
| Jun 6, 2022↗ | Blanks Robert | See Remarks | Sell | 73,312 | $0.65 | $47.7K | 0 |
| Jun 6, 2022↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 60,821 | $0.65 | $39.6K | 0 |
| Jun 6, 2022↗ | RAAB MICHAEL | President & CEO | Sell | 103,624 | $0.65 | $67.4K | 0 |
| Jun 6, 2022↗ | Renz Justin A | Chief Financial Officer | Sell | 73,312 | $0.65 | $47.7K | 0 |
| Jun 6, 2022↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 43,920 | $0.65 | $28.6K | 0 |
| Jun 6, 2022↗ | Rosenbaum David P. | Chief Development Officer | Sell | 61,640 | $0.65 | $40.1K | 0 |
| May 20, 2022↗ | Blanks Robert | See Remarks | Sell | 1,489 | $0.67 | $999.71 | 0 |
| May 20, 2022↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 1,263 | $0.67 | $847.98 | 0 |
| May 20, 2022↗ | RAAB MICHAEL | President & CEO | Sell | 6,124 | $0.67 | $4.1K | 0 |
| May 20, 2022↗ | Renz Justin A | Chief Financial Officer | Sell | 1,528 | $0.67 | $1.0K | 0 |
| May 20, 2022↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 3,425 | $0.67 | $2.3K | 0 |
| May 20, 2022↗ | Rosenbaum David P. | Chief Development Officer | Sell | 2,013 | $0.67 | $1.4K | 0 |
| Feb 22, 2022↗ | Blanks Robert | See Remarks | Sell | 1,752 | $0.67 | $1.2K | 0 |
| Feb 22, 2022↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 1,528 | $0.67 | $1.0K | 0 |
| Feb 22, 2022↗ | RAAB MICHAEL | President & CEO | Sell | 6,229 | $0.67 | $4.2K | 0 |
| Feb 22, 2022↗ | Renz Justin A | Chief Financial Officer | Sell | 1,800 | $0.67 | $1.2K | 0 |
| Feb 22, 2022↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 3,400 | $0.67 | $2.3K | 0 |
| Feb 22, 2022↗ | Rosenbaum David P. | Chief Development Officer | Sell | 2,353 | $0.67 | $1.6K | 0 |
| Dec 9, 2021↗ | BASKETT FOREST | 10% Owner | Sell | 2,881,570 | $1.26 | $3.64M | 0 |
| Dec 9, 2021↗ | SANDELL SCOTT D | 10% Owner | Sell | 2,881,570 | $1.26 | $3.64M | 0 |
| Nov 22, 2021↗ | Blanks Robert | See Remarks | Sell | 643 | $0.99 | $637.79 | 0 |
| Nov 22, 2021↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 537 | $0.99 | $532.65 | 0 |
| Nov 22, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 5,754 | $0.98 | $5.6K | 0 |
| Nov 22, 2021↗ | RAAB MICHAEL | President & CEO | Sell | 2,607 | $0.99 | $2.6K | 0 |
| Nov 22, 2021↗ | Renz Justin A | Chief Financial Officer | Sell | 643 | $0.99 | $637.79 | 0 |
| Nov 22, 2021↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 643 | $0.99 | $637.79 | 0 |
| Nov 22, 2021↗ | Rosenbaum David P. | Chief Development Officer | Sell | 827 | $0.99 | $820.28 | 0 |
| Nov 15, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 5,000 | $1.13 | $5.7K | 0 |
| Nov 12, 2021↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 77,432 | $1.13 | $87.1K | 0 |
| Nov 8, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 2,166 | $1.18 | $2.6K | 0 |
| Aug 20, 2021↗ | Blanks Robert | See Remarks | Sell | 631 | $1.32 | $832.92 | 0 |
| Aug 20, 2021↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 526 | $1.32 | $694.32 | 0 |
| Aug 20, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 741 | $1.32 | $978.12 | 0 |
| Aug 20, 2021↗ | RAAB MICHAEL | President & CEO | Sell | 2,573 | $1.32 | $3.4K | 0 |
| Aug 20, 2021↗ | Renz Justin A | Chief Financial Officer | Sell | 631 | $1.32 | $832.92 | 0 |
| Aug 20, 2021↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 630 | $1.32 | $831.60 | 0 |
| Aug 20, 2021↗ | Rosenbaum David P. | Chief Development Officer | Sell | 807 | $1.32 | $1.1K | 0 |
| Aug 3, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 5,613 | $1.64 | $9.2K | 0 |
| Aug 3, 2021↗ | RAAB MICHAEL | President & CEO | Sell | 150,343 | $1.64 | $246.6K | 0 |
| Jun 15, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 7,500 | $7.29 | $54.7K | 0 |
| May 28, 2021↗ | Rosenbaum David P. | Chief Development Officer | Sell | 3,062 | $7.22 | $22.1K | 0 |
| May 20, 2021↗ | Blanks Robert | See Remarks | Sell | 612 | $7.09 | $4.3K | 0 |
| May 20, 2021↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 508 | $7.09 | $3.6K | 0 |
| May 20, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 721 | $7.09 | $5.1K | 0 |
| May 20, 2021↗ | RAAB MICHAEL | President & CEO | Sell | 2,534 | $7.09 | $18.0K | 0 |
| May 20, 2021↗ | Renz Justin A | Chief Financial Officer | Sell | 612 | $7.09 | $4.3K | 0 |
| May 20, 2021↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 611 | $7.09 | $4.3K | 0 |
| May 20, 2021↗ | Rosenbaum David P. | Chief Development Officer | Sell | 769 | $7.09 | $5.5K | 0 |
| Apr 6, 2021↗ | Blanks Robert | See Remarks | Sell | 5,163 | $8.00 | $41.3K | 0 |
| Apr 6, 2021↗ | Rosenbaum David P. | Chief Development Officer | Sell | 5,000 | $8.00 | $40.0K | 0 |
| Feb 22, 2021↗ | Blanks Robert | See Remarks | Sell | 593 | $6.88 | $4.1K | 0 |
| Feb 22, 2021↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 504 | $6.88 | $3.5K | 0 |
| Feb 22, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 702 | $6.88 | $4.8K | 0 |
| Feb 22, 2021↗ | RAAB MICHAEL | President & CEO | Sell | 2,534 | $6.88 | $17.4K | 0 |
| Feb 22, 2021↗ | Renz Justin A | Chief Financial Officer | Sell | 608 | $6.88 | $4.2K | 0 |
| Feb 22, 2021↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 611 | $6.88 | $4.2K | 0 |
| Feb 22, 2021↗ | Rosenbaum David P. | Chief Development Officer | Sell | 805 | $6.88 | $5.5K | 0 |
ARDX Insider Buying Activity
The following table shows recent insider purchases of Ardelyx, Inc. (ARDX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026↗ | MOTT DAVID M | director | Buy | 333,333 | $5.84 | $1.95M | 3,302,920 |
| Feb 20, 2026↗ | MOTT DAVID M | Director | Buy | 333,333 | $5.84 | $1.95M | 0 |
| Jun 16, 2025↗ | MOTT DAVID M | Director | Buy | 200,000 | $3.63 | $725.9K | 0 |
| Jun 9, 2025↗ | MOTT DAVID M | Director | Buy | 200,000 | $3.69 | $737.3K | 0 |
| May 15, 2025↗ | MOTT DAVID M | Director | Buy | 100,000 | $3.29 | $329.1K | 0 |
| May 2, 2025↗ | MOTT DAVID M | Director | Buy | 381,377 | $4.22 | $1.61M | 0 |
| Feb 24, 2025↗ | MOTT DAVID M | Director | Buy | 77,729 | $5.00 | $388.7K | 0 |
| Jan 21, 2025↗ | MOTT DAVID M | Director | Buy | 199,000 | $4.99 | $992.7K | 0 |
| Dec 19, 2024↗ | MOTT DAVID M | Director | Buy | 213,300 | $4.67 | $996.6K | 0 |
| Nov 13, 2024↗ | MOTT DAVID M | Director | Buy | 215,868 | $4.62 | $996.6K | 0 |
| Nov 17, 2022↗ | MOTT DAVID M | Director | Buy | 567,000 | $1.76 | $1.00M | 0 |
| Aug 31, 2022↗ | Felsch Robert Ora | See Remarks | Buy | 3,000 | $0.62 | $1.9K | 0 |
| Aug 31, 2022↗ | GRAMMER ELIZABETH A | See Remarks | Buy | 3,000 | $0.62 | $1.9K | 0 |
| Aug 31, 2022↗ | RAAB MICHAEL | President & CEO | Buy | 3,000 | $0.62 | $1.9K | 0 |
| Aug 31, 2022↗ | Renz Justin A | Chief Financial Officer | Buy | 3,000 | $0.62 | $1.9K | 0 |
| Aug 31, 2022↗ | Rosenbaum David P. | Chief Development Officer | Buy | 3,000 | $0.62 | $1.9K | 0 |
| Aug 31, 2022↗ | Williams Laura A | Chief Medical Officer | Buy | 3,000 | $0.62 | $1.9K | 0 |
ARDX Insider Selling Activity
The following table shows recent insider sales of Ardelyx, Inc. (ARDX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026↗ | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $6.26 | $260.6K | 1,836,150 |
| Feb 23, 2026↗ | Bishop John E | officer: See Remarks | Sell | 3,179 | $5.85 | $18.6K | 339,538 |
| Feb 23, 2026↗ | Brady James Parker | officer: Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 263,221 |
| Feb 23, 2026↗ | Foster Eric Duane | officer: Chief Commercial Officer | Sell | 10,438 | $5.85 | $61.0K | 427,233 |
| Feb 23, 2026↗ | Hohenleitner Susan | officer: Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 230,780 |
| Feb 23, 2026↗ | Kelliher Mike | officer: See Remarks | Sell | 9,595 | $5.85 | $56.1K | 365,827 |
| Feb 23, 2026↗ | RAAB MICHAEL | director, officer: President & CEO | Sell | 45,980 | $5.85 | $268.8K | 1,862,570 |
| Feb 23, 2026↗ | Reilly Joseph James | officer: See Remarks | Sell | 4,991 | $5.85 | $29.2K | 152,394 |
| Feb 23, 2026↗ | Williams Laura A | officer: See Remarks | Sell | 8,176 | $5.85 | $47.8K | 437,066 |
| Feb 20, 2026↗ | Bishop John E | See Remarks | Sell | 3,179 | $5.85 | $18.6K | 0 |
| Feb 20, 2026↗ | Brady James Parker | Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 0 |
| Feb 20, 2026↗ | Foster Eric Duane | Chief Commercial Officer | Sell | 10,439 | $5.85 | $61.0K | 0 |
| Feb 20, 2026↗ | Hohenleitner Susan | Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 0 |
| Feb 20, 2026↗ | Kelliher Mike | See Remarks | Sell | 9,595 | $5.85 | $56.1K | 0 |
| Feb 20, 2026↗ | RAAB MICHAEL | President & CEO | Sell | 45,982 | $5.85 | $268.8K | 0 |
| Feb 20, 2026↗ | Reilly Joseph James | See Remarks | Sell | 4,991 | $5.85 | $29.2K | 0 |
| Feb 20, 2026↗ | Williams Laura A | See Remarks | Sell | 8,176 | $5.85 | $47.8K | 0 |
| Jan 9, 2026↗ | Williams Laura A | officer: Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 361,563 |
| Jan 8, 2026↗ | Williams Laura A | Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 0 |
| Nov 21, 2025↗ | Foster Eric Duane | Chief Commercial Officer | Sell | 5,814 | $5.54 | $32.2K | 0 |
| Nov 21, 2025↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 5,995 | $5.54 | $33.2K | 0 |
| Nov 21, 2025↗ | Kelliher Mike | See Remarks | Sell | 5,560 | $5.54 | $30.8K | 0 |
| Nov 21, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 46,887 | $5.54 | $259.6K | 0 |
| Nov 21, 2025↗ | Reilly Joseph James | See Remarks | Sell | 11,086 | $5.54 | $61.4K | 0 |
| Nov 21, 2025↗ | Williams Laura A | Chief Patient Officer | Sell | 6,426 | $5.54 | $35.6K | 0 |
| Aug 26, 2025↗ | Williams Laura A | Chief Patient Officer | Sell | 80,000 | $6.12 | $489.7K | 0 |
| Aug 21, 2025↗ | Foster Eric Duane | Chief Commercial Officer | Sell | 15,308 | $5.93 | $90.8K | 0 |
| Aug 21, 2025↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 5,841 | $5.93 | $34.6K | 0 |
| Aug 21, 2025↗ | Kelliher Mike | Chief Business Officer | Sell | 5,417 | $5.93 | $32.1K | 0 |
| Aug 21, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 45,687 | $5.93 | $271.0K | 0 |
| Aug 21, 2025↗ | Renz Justin A | Chief Financial Officer | Sell | 7,037 | $5.93 | $41.7K | 0 |
| Aug 21, 2025↗ | Williams Laura A | Chief Patient Officer | Sell | 6,261 | $5.93 | $37.1K | 0 |
| May 20, 2025↗ | Foster Eric Duane | Chief Commercial Officer | Sell | 2,507 | $4.08 | $10.2K | 0 |
| May 20, 2025↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 5,992 | $4.08 | $24.5K | 0 |
| May 20, 2025↗ | Kelliher Mike | See Remarks | Sell | 14,522 | $4.08 | $59.3K | 0 |
| May 20, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 46,817 | $4.08 | $191.1K | 0 |
| May 20, 2025↗ | Renz Justin A | Chief Financial Officer | Sell | 7,218 | $4.08 | $29.5K | 0 |
| May 20, 2025↗ | Williams Laura A | Chief Medical Officer | Sell | 6,421 | $4.08 | $26.2K | 0 |
| May 2, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 41,666 | $4.25 | $177.2K | 0 |
| Apr 4, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 41,666 | $4.59 | $191.2K | 0 |
| Mar 7, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 41,668 | $5.36 | $223.2K | 0 |
| Feb 20, 2025↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 4,291 | $5.62 | $24.1K | 0 |
| Feb 20, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 22,964 | $5.62 | $129.1K | 0 |
| Feb 20, 2025↗ | Renz Justin A | Chief Financial Officer | Sell | 5,171 | $5.62 | $29.1K | 0 |
| Feb 20, 2025↗ | Williams Laura A | Chief Medical Officer | Sell | 4,941 | $5.62 | $27.8K | 0 |
| Jan 31, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 41,666 | $5.36 | $223.4K | 0 |
| Jan 7, 2025↗ | RAAB MICHAEL | President & CEO | Sell | 41,666 | $5.31 | $221.3K | 0 |
| Dec 10, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 25,000 | $5.26 | $131.6K | 0 |
| Nov 25, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 25,000 | $5.38 | $134.5K | 0 |
| Nov 20, 2024↗ | Blanks Robert | See Remarks | Sell | 4,941 | $4.79 | $23.7K | 0 |
| Nov 20, 2024↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 7,046 | $4.79 | $33.8K | 0 |
| Nov 20, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 31,980 | $4.79 | $153.3K | 0 |
| Nov 20, 2024↗ | Renz Justin A | Chief Financial Officer | Sell | 5,260 | $4.79 | $25.2K | 0 |
| Nov 20, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 7,184 | $4.79 | $34.4K | 0 |
| Nov 20, 2024↗ | Williams Laura A | Chief Medical Officer | Sell | 7,366 | $4.79 | $35.3K | 0 |
| Nov 11, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 2,743 | $4.90 | $13.4K | 0 |
| Nov 6, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 27,171 | $6.10 | $165.7K | 0 |
| Nov 4, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 27,172 | $5.95 | $161.7K | 0 |
| Oct 28, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 25,000 | $5.91 | $147.7K | 0 |
| Oct 11, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 7,500 | $6.01 | $45.1K | 0 |
| Sep 27, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 49,564 | $6.92 | $343.0K | 0 |
| Sep 26, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 3,000 | $6.07 | $18.2K | 0 |
| Sep 13, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 5,312 | $6.26 | $33.3K | 0 |
| Sep 11, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 35,000 | $5.61 | $196.4K | 0 |
| Aug 27, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 7,500 | $6.22 | $46.6K | 0 |
| Aug 20, 2024↗ | Blanks Robert | See Remarks | Sell | 4,969 | $5.86 | $29.1K | 0 |
| Aug 20, 2024↗ | Felsch Robert Ora | See Remarks | Sell | 3,567 | $5.86 | $20.9K | 0 |
| Aug 20, 2024↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 7,089 | $5.86 | $41.5K | 0 |
| Aug 20, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 32,225 | $5.86 | $188.8K | 0 |
| Aug 20, 2024↗ | Renz Justin A | Chief Financial Officer | Sell | 5,289 | $5.86 | $31.0K | 0 |
| Aug 20, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 7,219 | $5.86 | $42.3K | 0 |
| Aug 20, 2024↗ | Williams Laura A | Chief Medical Officer | Sell | 7,412 | $5.86 | $43.4K | 0 |
| Aug 16, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 40,507 | $5.97 | $241.8K | 0 |
| Aug 12, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 1,229 | $5.71 | $7.0K | 0 |
| Jul 29, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 30,000 | $5.64 | $169.3K | 0 |
| Jul 15, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 7,500 | $5.97 | $44.8K | 0 |
| Jun 28, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 2,310 | $6.59 | $15.2K | 0 |
| Jun 21, 2024↗ | Blanks Robert | See Remarks | Sell | 38,000 | $5.96 | $226.3K | 0 |
| Jun 13, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 35,000 | $6.65 | $232.7K | 0 |
| Jun 5, 2024↗ | Williams Laura A | Chief Medical Officer | Sell | 145,000 | $7.12 | $1.03M | 0 |
| Jun 3, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 17,872 | $7.00 | $125.1K | 0 |
| May 29, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 7,500 | $6.72 | $50.4K | 0 |
| May 21, 2024↗ | Blanks Robert | See Remarks | Sell | 4,855 | $7.81 | $37.9K | 0 |
| May 21, 2024↗ | Felsch Robert Ora | See Remarks | Sell | 3,485 | $7.81 | $27.2K | 0 |
| May 21, 2024↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 6,927 | $7.81 | $54.1K | 0 |
| May 21, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 31,484 | $7.81 | $245.9K | 0 |
| May 21, 2024↗ | Renz Justin A | Chief Financial Officer | Sell | 5,167 | $7.81 | $40.4K | 0 |
| May 21, 2024↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 6,703 | $7.81 | $52.4K | 0 |
| May 21, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 7,053 | $7.81 | $55.1K | 0 |
| May 21, 2024↗ | Williams Laura A | Chief Medical Officer | Sell | 4,794 | $7.81 | $37.4K | 0 |
| May 14, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 3,000 | $7.99 | $24.0K | 0 |
| May 6, 2024↗ | Felsch Robert Ora | See Remarks | Sell | 207,988 | $8.81 | $1.83M | 0 |
| May 6, 2024↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 284,170 | $8.88 | $2.52M | 0 |
| May 3, 2024↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 45,000 | $9.00 | $405.0K | 0 |
| May 3, 2024↗ | Williams Laura A | Chief Medical Officer | Sell | 39,949 | $8.35 | $333.6K | 0 |
| Apr 29, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 30,000 | $6.40 | $192.1K | 0 |
| Apr 15, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 7,500 | $7.06 | $52.9K | 0 |
| Apr 1, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 1,518 | $7.31 | $11.1K | 0 |
| Mar 20, 2024↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 86,000 | $7.73 | $665.0K | 0 |
| Feb 26, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 5,183 | $9.20 | $47.7K | 0 |
| Feb 20, 2024↗ | Blanks Robert | See Remarks | Sell | 5,017 | $8.75 | $43.9K | 0 |
| Feb 20, 2024↗ | Felsch Robert Ora | See Remarks | Sell | 2,352 | $8.75 | $20.6K | 0 |
| Feb 20, 2024↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 4,432 | $8.75 | $38.8K | 0 |
| Feb 20, 2024↗ | RAAB MICHAEL | President & CEO | Sell | 22,917 | $8.75 | $200.4K | 0 |
| Feb 20, 2024↗ | Renz Justin A | Chief Financial Officer | Sell | 5,341 | $8.75 | $46.7K | 0 |
| Feb 20, 2024↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 6,928 | $8.75 | $60.6K | 0 |
| Feb 20, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 7,311 | $8.75 | $63.9K | 0 |
| Feb 20, 2024↗ | Williams Laura A | Chief Medical Officer | Sell | 4,803 | $8.75 | $42.0K | 0 |
| Feb 8, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 15,344 | $9.18 | $140.8K | 0 |
| Jan 8, 2024↗ | Rosenbaum David P. | Chief Development Officer | Sell | 30,000 | $6.64 | $199.2K | 0 |
| Dec 26, 2023↗ | Renz Justin A | Chief Financial Officer | Sell | 225,000 | $6.36 | $1.43M | 0 |
| Dec 18, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 5,675 | $6.07 | $34.4K | 0 |
| Dec 14, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 7,000 | $5.55 | $38.9K | 0 |
| Dec 11, 2023↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 50,000 | $5.08 | $253.9K | 0 |
| Dec 8, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 20,000 | $5.27 | $105.5K | 0 |
| Dec 5, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 10,272 | $5.00 | $51.4K | 0 |
| Nov 30, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 3,000 | $4.50 | $13.5K | 0 |
| Nov 20, 2023↗ | Blanks Robert | See Remarks | Sell | 2,835 | $4.36 | $12.4K | 0 |
| Nov 20, 2023↗ | Felsch Robert Ora | See Remarks | Sell | 1,044 | $4.36 | $4.6K | 0 |
| Nov 20, 2023↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 2,384 | $4.36 | $10.4K | 0 |
| Nov 20, 2023↗ | RAAB MICHAEL | President & CEO | Sell | 11,368 | $4.36 | $49.6K | 0 |
| Nov 20, 2023↗ | Renz Justin A | Chief Financial Officer | Sell | 2,873 | $4.36 | $12.5K | 0 |
| Nov 20, 2023↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 4,714 | $4.36 | $20.6K | 0 |
| Nov 20, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 3,767 | $4.36 | $16.4K | 0 |
| Nov 20, 2023↗ | Williams Laura A | Chief Medical Officer | Sell | 2,581 | $4.36 | $11.3K | 0 |
| Nov 15, 2023↗ | Williams Laura A | Chief Medical Officer | Sell | 25,000 | $4.00 | $100.0K | 0 |
| Oct 10, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 1,644 | $4.00 | $6.6K | 0 |
| Sep 8, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 2,897 | $4.55 | $13.2K | 0 |
| Aug 21, 2023↗ | Blanks Robert | See Remarks | Sell | 2,846 | $3.55 | $10.1K | 0 |
| Aug 21, 2023↗ | Felsch Robert Ora | See Remarks | Sell | 1,048 | $3.55 | $3.7K | 0 |
| Aug 21, 2023↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 2,392 | $3.55 | $8.5K | 0 |
| Aug 21, 2023↗ | RAAB MICHAEL | President & CEO | Sell | 11,419 | $3.55 | $40.6K | 0 |
| Aug 21, 2023↗ | Renz Justin A | Chief Financial Officer | Sell | 2,884 | $3.55 | $10.2K | 0 |
| Aug 21, 2023↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 4,733 | $3.55 | $16.8K | 0 |
| Aug 21, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 3,783 | $3.55 | $13.4K | 0 |
| Aug 21, 2023↗ | Williams Laura A | Chief Medical Officer | Sell | 2,591 | $3.55 | $9.2K | 0 |
| Jun 27, 2023↗ | Williams Laura A | Chief Medical Officer | Sell | 25,000 | $3.35 | $83.6K | 0 |
| Jun 23, 2023↗ | Blanks Robert | See Remarks | Sell | 33,333 | $3.63 | $121.0K | 0 |
| May 23, 2023↗ | Blanks Robert | See Remarks | Sell | 2,835 | $3.65 | $10.4K | 0 |
| May 23, 2023↗ | Felsch Robert Ora | See Remarks | Sell | 1,046 | $3.65 | $3.8K | 0 |
| May 23, 2023↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 2,384 | $3.65 | $8.7K | 0 |
| May 23, 2023↗ | RAAB MICHAEL | President & CEO | Sell | 11,357 | $3.65 | $41.5K | 0 |
| May 23, 2023↗ | Renz Justin A | Chief Financial Officer | Sell | 2,873 | $3.65 | $10.5K | 0 |
| May 23, 2023↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 4,711 | $3.65 | $17.2K | 0 |
| May 23, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 3,769 | $3.65 | $13.8K | 0 |
| May 23, 2023↗ | Williams Laura A | Chief Medical Officer | Sell | 2,583 | $3.65 | $9.4K | 0 |
| Mar 29, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 3,000 | $4.63 | $13.9K | 0 |
| Feb 21, 2023↗ | Blanks Robert | See Remarks | Sell | 3,394 | $3.00 | $10.2K | 0 |
| Feb 21, 2023↗ | Felsch Robert Ora | See Remarks | Sell | 3,214 | $3.00 | $9.6K | 0 |
| Feb 21, 2023↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 2,914 | $3.00 | $8.7K | 0 |
| Feb 21, 2023↗ | RAAB MICHAEL | President & CEO | Sell | 13,449 | $3.00 | $40.4K | 0 |
| Feb 21, 2023↗ | Renz Justin A | Chief Financial Officer | Sell | 3,439 | $3.00 | $10.3K | 0 |
| Feb 21, 2023↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 5,586 | $3.00 | $16.8K | 0 |
| Feb 21, 2023↗ | Rosenbaum David P. | Chief Development Officer | Sell | 4,508 | $3.00 | $13.5K | 0 |
| Feb 21, 2023↗ | Williams Laura A | Chief Medical Officer | Sell | 3,187 | $3.00 | $9.6K | 0 |
| Nov 22, 2022↗ | Blanks Robert | See Remarks | Sell | 1,464 | $1.95 | $2.9K | 0 |
| Nov 22, 2022↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 1,242 | $1.95 | $2.4K | 0 |
| Nov 22, 2022↗ | RAAB MICHAEL | President & CEO | Sell | 6,219 | $1.95 | $12.1K | 0 |
| Nov 22, 2022↗ | Renz Justin A | Chief Financial Officer | Sell | 1,504 | $1.95 | $2.9K | 0 |
| Nov 22, 2022↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 3,456 | $1.95 | $6.7K | 0 |
| Nov 22, 2022↗ | Rosenbaum David P. | Chief Development Officer | Sell | 1,948 | $1.95 | $3.8K | 0 |
| Nov 22, 2022↗ | Williams Laura A | Chief Medical Officer | Sell | 1,241 | $1.95 | $2.4K | 0 |
| Oct 5, 2022↗ | Blanks Robert | See Remarks | Sell | 100,000 | $1.50 | $150.0K | 0 |
| Aug 31, 2022↗ | Rosenbaum David P. | Chief Development Officer | Sell | 3,000 | $0.92 | $2.8K | 0 |
| Aug 26, 2022↗ | Blanks Robert | See Remarks | Sell | 21,842 | $1.04 | $22.7K | 0 |
| Aug 22, 2022↗ | Blanks Robert | See Remarks | Sell | 1,458 | $0.98 | $1.4K | 0 |
| Aug 22, 2022↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 1,236 | $0.98 | $1.2K | 0 |
| Aug 22, 2022↗ | RAAB MICHAEL | President & CEO | Sell | 6,146 | $0.98 | $6.0K | 0 |
| Aug 22, 2022↗ | Renz Justin A | Chief Financial Officer | Sell | 1,498 | $0.98 | $1.5K | 0 |
| Aug 22, 2022↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 3,420 | $0.98 | $3.4K | 0 |
| Aug 22, 2022↗ | Rosenbaum David P. | Chief Development Officer | Sell | 1,955 | $0.98 | $1.9K | 0 |
| Aug 22, 2022↗ | Williams Laura A | Chief Medical Officer | Sell | 1,276 | $0.98 | $1.3K | 0 |
| Jul 26, 2022↗ | Blanks Robert | See Remarks | Sell | 5,188 | $0.67 | $3.5K | 0 |
| Jun 6, 2022↗ | Blanks Robert | See Remarks | Sell | 73,312 | $0.65 | $47.7K | 0 |
| Jun 6, 2022↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 60,821 | $0.65 | $39.6K | 0 |
| Jun 6, 2022↗ | RAAB MICHAEL | President & CEO | Sell | 103,624 | $0.65 | $67.4K | 0 |
| Jun 6, 2022↗ | Renz Justin A | Chief Financial Officer | Sell | 73,312 | $0.65 | $47.7K | 0 |
| Jun 6, 2022↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 43,920 | $0.65 | $28.6K | 0 |
| Jun 6, 2022↗ | Rosenbaum David P. | Chief Development Officer | Sell | 61,640 | $0.65 | $40.1K | 0 |
| May 20, 2022↗ | Blanks Robert | See Remarks | Sell | 1,489 | $0.67 | $999.71 | 0 |
| May 20, 2022↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 1,263 | $0.67 | $847.98 | 0 |
| May 20, 2022↗ | RAAB MICHAEL | President & CEO | Sell | 6,124 | $0.67 | $4.1K | 0 |
| May 20, 2022↗ | Renz Justin A | Chief Financial Officer | Sell | 1,528 | $0.67 | $1.0K | 0 |
| May 20, 2022↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 3,425 | $0.67 | $2.3K | 0 |
| May 20, 2022↗ | Rosenbaum David P. | Chief Development Officer | Sell | 2,013 | $0.67 | $1.4K | 0 |
| Feb 22, 2022↗ | Blanks Robert | See Remarks | Sell | 1,752 | $0.67 | $1.2K | 0 |
| Feb 22, 2022↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 1,528 | $0.67 | $1.0K | 0 |
| Feb 22, 2022↗ | RAAB MICHAEL | President & CEO | Sell | 6,229 | $0.67 | $4.2K | 0 |
| Feb 22, 2022↗ | Renz Justin A | Chief Financial Officer | Sell | 1,800 | $0.67 | $1.2K | 0 |
| Feb 22, 2022↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 3,400 | $0.67 | $2.3K | 0 |
| Feb 22, 2022↗ | Rosenbaum David P. | Chief Development Officer | Sell | 2,353 | $0.67 | $1.6K | 0 |
| Dec 9, 2021↗ | BASKETT FOREST | 10% Owner | Sell | 2,881,570 | $1.26 | $3.64M | 0 |
| Dec 9, 2021↗ | SANDELL SCOTT D | 10% Owner | Sell | 2,881,570 | $1.26 | $3.64M | 0 |
| Nov 22, 2021↗ | Blanks Robert | See Remarks | Sell | 643 | $0.99 | $637.79 | 0 |
| Nov 22, 2021↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 537 | $0.99 | $532.65 | 0 |
| Nov 22, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 5,754 | $0.98 | $5.6K | 0 |
| Nov 22, 2021↗ | RAAB MICHAEL | President & CEO | Sell | 2,607 | $0.99 | $2.6K | 0 |
| Nov 22, 2021↗ | Renz Justin A | Chief Financial Officer | Sell | 643 | $0.99 | $637.79 | 0 |
| Nov 22, 2021↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 643 | $0.99 | $637.79 | 0 |
| Nov 22, 2021↗ | Rosenbaum David P. | Chief Development Officer | Sell | 827 | $0.99 | $820.28 | 0 |
| Nov 15, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 5,000 | $1.13 | $5.7K | 0 |
| Nov 12, 2021↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 77,432 | $1.13 | $87.1K | 0 |
| Nov 8, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 2,166 | $1.18 | $2.6K | 0 |
| Aug 20, 2021↗ | Blanks Robert | See Remarks | Sell | 631 | $1.32 | $832.92 | 0 |
| Aug 20, 2021↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 526 | $1.32 | $694.32 | 0 |
| Aug 20, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 741 | $1.32 | $978.12 | 0 |
| Aug 20, 2021↗ | RAAB MICHAEL | President & CEO | Sell | 2,573 | $1.32 | $3.4K | 0 |
| Aug 20, 2021↗ | Renz Justin A | Chief Financial Officer | Sell | 631 | $1.32 | $832.92 | 0 |
| Aug 20, 2021↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 630 | $1.32 | $831.60 | 0 |
| Aug 20, 2021↗ | Rosenbaum David P. | Chief Development Officer | Sell | 807 | $1.32 | $1.1K | 0 |
| Aug 3, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 5,613 | $1.64 | $9.2K | 0 |
| Aug 3, 2021↗ | RAAB MICHAEL | President & CEO | Sell | 150,343 | $1.64 | $246.6K | 0 |
| Jun 15, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 7,500 | $7.29 | $54.7K | 0 |
| May 28, 2021↗ | Rosenbaum David P. | Chief Development Officer | Sell | 3,062 | $7.22 | $22.1K | 0 |
| May 20, 2021↗ | Blanks Robert | See Remarks | Sell | 612 | $7.09 | $4.3K | 0 |
| May 20, 2021↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 508 | $7.09 | $3.6K | 0 |
| May 20, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 721 | $7.09 | $5.1K | 0 |
| May 20, 2021↗ | RAAB MICHAEL | President & CEO | Sell | 2,534 | $7.09 | $18.0K | 0 |
| May 20, 2021↗ | Renz Justin A | Chief Financial Officer | Sell | 612 | $7.09 | $4.3K | 0 |
| May 20, 2021↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 611 | $7.09 | $4.3K | 0 |
| May 20, 2021↗ | Rosenbaum David P. | Chief Development Officer | Sell | 769 | $7.09 | $5.5K | 0 |
| Apr 6, 2021↗ | Blanks Robert | See Remarks | Sell | 5,163 | $8.00 | $41.3K | 0 |
| Apr 6, 2021↗ | Rosenbaum David P. | Chief Development Officer | Sell | 5,000 | $8.00 | $40.0K | 0 |
| Feb 22, 2021↗ | Blanks Robert | See Remarks | Sell | 593 | $6.88 | $4.1K | 0 |
| Feb 22, 2021↗ | GRAMMER ELIZABETH A | See Remarks | Sell | 504 | $6.88 | $3.5K | 0 |
| Feb 22, 2021↗ | Jacobs Jeffrey W | Chief Scientific Officer | Sell | 702 | $6.88 | $4.8K | 0 |
| Feb 22, 2021↗ | RAAB MICHAEL | President & CEO | Sell | 2,534 | $6.88 | $17.4K | 0 |
| Feb 22, 2021↗ | Renz Justin A | Chief Financial Officer | Sell | 608 | $6.88 | $4.2K | 0 |
| Feb 22, 2021↗ | Rodriguez Susan | Chief Commercial Officer | Sell | 611 | $6.88 | $4.2K | 0 |
| Feb 22, 2021↗ | Rosenbaum David P. | Chief Development Officer | Sell | 805 | $6.88 | $5.5K | 0 |
ARDX Insiders
Similar Stocks to ARDX
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$538.00+0.97%
$21.50B
INCY
Incyte Corporation
$92.25+0.27%
$20.10B
RVMD
Revolution Medicines, Inc.
$95.44+0.39%
$20.10B
MRNA
Moderna, Inc.
$52.38-1.89%
$19.96B